Professor, Vice Chair and Program Director
Geisinger
Wilkes Barre, Pennsylvania, United States
Clemens M. Schirmer, MD, PhD, MBA, FAANS, FACS, FAHA earned his medical degree and a doctorate in medical research from Ludwig-Maximilians University in Munich, Germany and at Harvard Medical School under the auspices of the Harvard Munich Alliance for Medical Education. He then completed his residency in Neurosurgery and fellowship in Interventional Neuroradiology at the Tufts Medical Center program in Boston. He recently returned to school and completed the TRIUM global MBA program, jointly awarded by the London School of Economics, Ecole des hautes etudes commercials de Paris (HEC) and New York University Stern School of Business.
ABNS board certified in neurological surgery and holding subspecialty board recognition of focused practice (RFP) certificates both in neuroendovascular surgery and neurocritical care, he currently serves as Vice Chair in the Department of Neurosurgery and holds the rank of full Professor of Neurosurgery and Neuroscience in the unmodified research track at the Geisinger Commonwealth School of Medicine. He also serves as the System Director of the Geisinger Comprehensive Stroke Centers and System Director of Cerebrovascular and Endovascular Neurosurgery, specializing in the treatment of stroke and related vascular disorders of the brain and spine using surgery, endovascular and radiation modalities. He is the Program director of the Geisinger Neurosurgery residency training program and the CAST Neuroendovascular Fellowship program.
His research interests focus on the quality metrics, variation of care, shared decision making and patient centered outcomes, genomics and biomarkers of stroke, machine learning and data analytics. He serves as principal investigator of numerous clinical trials in the stroke arena aiming to bringing novel and innovative therapies to the market and creating premier Geisinger initiatives such as Early Recovery, ProvenCare and ProvenExperience.
He serves as chair of the the AANS/CNS Joint Cerebrovascular Section and the executive committee of the Congress of Neurological Surgeons where he is co-chair of the Development Committee and Co-Editor of the CongressQuarterly and on the board of the CNS foundation, chair of the public relations and communications subcommittee of the Joint Washington Committee between the CNS and AANS and Advisor to the AMA RBRVS RUC committee. He has been appointed to MEDCAC and appointed to the Premier Group Purchasing Organization Member Cardiovascular Advisory Committee and multiple CMS/Acumen Cost- and Medicare Spending per Beneficiary- Measure Development Panels.
(PC2206) Practical Clinic: 2023 Coding and CPT Update
Friday, April 21, 2023
1:00pm – 4:30pm PST
Disclosure(s): Balt: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Cerenovus: Grant/Research Support (Ongoing), Research Grant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); MIVI Neuroscience: Grant/Research Support (Ongoing), Research Grant (Ongoing); NTI: Ownership Interest (Ongoing); Penumbra: Grant/Research Support (Ongoing), Research Grant (Ongoing); Stryker: Grant/Research Support (Ongoing), Research Grant (Ongoing); Werfen: Speaker/Honoraria (Terminated, December 31, 2022)
(NC5501) Policy and Cerebrovascular Care
Monday, April 24, 2023
9:03am – 9:43am PST
Disclosure(s): Balt: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Cerenovus: Grant/Research Support (Ongoing), Research Grant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); MIVI Neuroscience: Grant/Research Support (Ongoing), Research Grant (Ongoing); NTI: Ownership Interest (Ongoing); Penumbra: Grant/Research Support (Ongoing), Research Grant (Ongoing); Stryker: Grant/Research Support (Ongoing), Research Grant (Ongoing); Werfen: Speaker/Honoraria (Terminated, December 31, 2022)
(NC5501) Panel Discussion: Refining Access to Cerebrovascular Neurosurgery
Monday, April 24, 2023
10:25am – 11:00am PST
Disclosure(s): Balt: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Cerenovus: Grant/Research Support (Ongoing), Research Grant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); MIVI Neuroscience: Grant/Research Support (Ongoing), Research Grant (Ongoing); NTI: Ownership Interest (Ongoing); Penumbra: Grant/Research Support (Ongoing), Research Grant (Ongoing); Stryker: Grant/Research Support (Ongoing), Research Grant (Ongoing); Werfen: Speaker/Honoraria (Terminated, December 31, 2022)